AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14602763 — intervention group
Group type: COMPARATOR
Intervention: L-T4
Number of subjects: 36
Study 10764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncorrected visual acuity 0.50 (20/40) or worse in at least one eye
Number of subjects: 5303
Study 10764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Presenting visual acuity 0.50 (20/40) or worse in at least one eye
Number of subjects: 5303
Study 10764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Best visual acuity 0.50 (20/40) or worse in at least one eye
Number of subjects: 5303
Study 10764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Best visual acuity 0.50 or worse in both eyes
Number of subjects: 5303
Study 10764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Refractive error as a cause of reduced vision
Number of subjects: 5303
Study 10764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Amblyopia as a cause of reduced vision
Number of subjects: 5303
Study 10764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Other causes of reduced vision
Number of subjects: 5303
Study 10764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Unexplained causes of reduced vision
Number of subjects: 5303
Study 10764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Myopia (‐0.50 diopter or less) in 5-year-old children
Number of subjects: 5303
Study 10764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Myopia (‐0.50 diopter or less) in males by age 15
Number of subjects: 5303
Study 10764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Myopia (‐0.50 diopter or less) in females by age 15
Number of subjects: 5303
Study 10764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperopia (2.00 diopters or greater) in males from age 5 to 15
Number of subjects: 5303
Study 10764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperopia (2.00 diopters or greater) in females from age 5 to 15
Number of subjects: 5303
Study 10764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk of hyperopia in females compared to males
Number of subjects: 5303
Study 10764851 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of proper spectacles
Number of subjects: 5303
Study 8775350 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physical training (PT) - 5 days/week for 10 weeks
Number of subjects: 12
Study 8775350 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle education (LSE) - Weekly lifestyle discussions
Number of subjects: 12
Study 8775350 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PT and LSE
Number of subjects: 12
Study 1602037 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine strips
Number of subjects: 73
Study 1602037 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole strips
Number of subjects: 73
Study 1602037 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline strips
Number of subjects: 73
Study 1602037 — intervention group
Group type: EXPERIMENTAL
Intervention: Root planing
Number of subjects: 73
Study 1602037 — intervention group
Group type: EXPERIMENTAL
Intervention: Root planing followed by metronidazole strips
Number of subjects: 73
Study 1602037 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 73
Study 6463068 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg oxiconazole (one vaginal tablet)
Number of subjects: 51
Study 6463068 — intervention group
Group type: COMPARATOR
Intervention: 150 mg econazole (one ovule daily for 3 days)
Number of subjects: 51
Study 6463068 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg oxiconazole
Number of subjects: 51
Study 6463068 — intervention group
Group type: COMPARATOR
Intervention: 150 mg econazole
Number of subjects: 51
Study 31905348 — intervention group
Group type: EXPERIMENTAL
Intervention: GINA guidelines + FENO modification for ICS titration (group 2)
Number of subjects: 224
Study 31905348 — intervention group
Group type: COMPARATOR
Intervention: GINA guidelines (group 1)
Number of subjects: 224
Study 31571632 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS (1200 pulses in eight trains of 150 pulses each at 1Hz over the right dorsolateral prefrontal cortex)
Number of subjects: 30
Study 31571632 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 30
Study 31571632 — intervention group
Group type: COMPARATOR
Intervention: Placebo (rTMS coil placed such that magnetic stimulation did not reach the cortex)
Number of subjects: 30
Study 28546012 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 1 mg.kg−1
Number of subjects: 90
Study 28546012 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 1 mcg.kg−1
Number of subjects: 90
Study 28546012 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 mcg.kg−1
Number of subjects: 90
Study 28768070 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive neurological and oculomotor exam; balance testing (Berg Balance Scale-BBS; Romberg Test-RT, Sharpened Romberg Test-SRT); olfactory function (Brief Smell Identification Test-BSIT)
Number of subjects: 71
Study 24530273 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine 10 mg/day (n=133)
Number of subjects: 549
Study 24530273 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine 25 mg/day (n=138)
Number of subjects: 549
Study 24530273 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine 25-50 mg/day (n=137)
Number of subjects: 549
Study 24530273 — intervention group
Group type: COMPARATOR
Intervention: Agomelatine 10 mg/day
Number of subjects: 549
Study 24530273 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine 25 mg/day
Number of subjects: 549
Study 24530273 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine 25-50 mg/day
Number of subjects: 549
Study 24530273 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine 25 mg and 25-50 mg/day
Number of subjects: 549
Study 24530273 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine (all doses)
Number of subjects: 549
Study 22397639 — intervention group
Group type: EXPERIMENTAL
Intervention: COACHES program
Number of subjects: 55
Study 22397639 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 55
Study 22397639 — intervention group
Group type: COMPARATOR
Intervention: Untreated mothers
Number of subjects: 55
Study 20093327 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling intervention (30 sessions over 12 weeks)
Number of subjects: 62
Study 20093327 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 62
Study 17522858 — intervention group
Group type: EXPERIMENTAL
Intervention: Clerad's GammaSup with a collimated CsI(Tl) scintillator
Number of subjects: 7
Study 17522858 — intervention group
Group type: EXPERIMENTAL
Intervention: Novelec's Modelo2 with a BGO scintillator
Number of subjects: 7
Study 17522858 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioguided surgery using (18)F-FDG PET
Number of subjects: 7
Study 15865948 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver demand and control
Number of subjects: 138
Study 15865948 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreasing control and increasing demand
Number of subjects: 138
Study 15002600 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary treatment including high caloric intake, Calcium and Vitamin D supplementation
Number of subjects: 19
Study 15002600 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 19
Study 9691101 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate 1600 mg per day orally for two years
Number of subjects: 302
Study 9691101 — intervention group
Group type: COMPARATOR
Intervention: Standard follow-up
Number of subjects: 302
Study 7635030 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (Taxol‐Bristol‐Myers Squibb)
Number of subjects: 0
Study 2751923 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 22
Study 2751923 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 22
Study 922295 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive plastic drape
Number of subjects: 144
Study 922295 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic ring protector
Number of subjects: 144
Study 922295 — intervention group
Group type: COMPARATOR
Intervention: Standard cloth towels (Control group A)
Number of subjects: 144
Study 29149790 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapist-led physical exercise intervention
Number of subjects: 0
Study 29149790 — intervention group
Group type: COMPARATOR
Intervention: Cohen-Mansfield Agitation Inventory
Number of subjects: 0
Study 31455577 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive note condition (90% of peers completed the task in less than 5 minutes)
Number of subjects: 40
Study 31455577 — intervention group
Group type: COMPARATOR
Intervention: Negative note condition (10% of peers completed the task in less than 5 minutes)
Number of subjects: 40
Study 28695815 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-air warming system
Number of subjects: 62
Study 28695815 — intervention group
Group type: COMPARATOR
Intervention: Conventional warming care
Number of subjects: 62
Study 24655152 — intervention group
Group type: EXPERIMENTAL
Intervention: Prioritizing attention on reaction time (RT) tasks
Number of subjects: 20
Study 23223867 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel (with or without loading dose)
Number of subjects: 95
Study 23223867 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 95
Study 21669954 — intervention group
Group type: EXPERIMENTAL
Intervention: dexamethasone 0.1 mg kg(‐1)
Number of subjects: 106
Study 21669954 — intervention group
Group type: COMPARATOR
Intervention: dexamethasone 0.05 mg kg(‐1)
Number of subjects: 106
Study 21669954 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 106
Study 19382426 — intervention group
Group type: EXPERIMENTAL
Intervention: TPN supplemented with GLN dipeptide
Number of subjects: 40
Study 19382426 — intervention group
Group type: COMPARATOR
Intervention: TPN without GLN dipeptide
Number of subjects: 40
Study 16906286 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomato paste (50 g daily for 10 weeks)
Number of subjects: 43
Study 15335128 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated behavioral health care
Number of subjects: 127
Study 15335128 — intervention group
Group type: COMPARATOR
Intervention: Enhanced referral care
Number of subjects: 127
Study 11146347 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic Arnica CH5
Number of subjects: 130
Study 11146347 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 9250266 — intervention group
Group type: EXPERIMENTAL
Intervention: sulphamethoxazole‐trimethoprim
Number of subjects: 0
Study 9250266 — intervention group
Group type: COMPARATOR
Intervention: dapsone/pyrimethamine
Number of subjects: 0
Study 8877185 — intervention group
Group type: EXPERIMENTAL
Intervention: Active device (pulsed electromagnetic stimulation)
Number of subjects: 58
Study 8877185 — intervention group
Group type: COMPARATOR
Intervention: Placebo device
Number of subjects: 58
Study 3522312 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (Tamofen, Leiras, or Nolvadex, ICI) 20 mg twice daily for 16 weeks
Number of subjects: 16
Study 31296045 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG 1064 nm short-pulse laser
Number of subjects: 51
Study 31296045 — intervention group
Group type: COMPARATOR
Intervention: Placebo sham laser
Number of subjects: 51
Study 30100292 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated neurodynamic treatment (special care)
Number of subjects: 10
Study 30100292 — intervention group
Group type: COMPARATOR
Intervention: Standard dysarthria treatment (usual care)
Number of subjects: 10
Study 30100292 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between groups
Number of subjects: 10
Study 27163986 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg macitentan
Number of subjects: 554
Study 27163986 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg macitentan
Number of subjects: 554
Study 27163986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 554
Study 24582801 — intervention group
Group type: EXPERIMENTAL
Intervention: Thromboembolism (HR=1.95, <1 year after diagnosis; HR=7.83, 1-5 years after diagnosis)
Number of subjects: 11139
Study 24582801 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematologic complications (HR=1.84, <1 year after diagnosis; HR=7.11, 1-5 years after diagnosis)
Number of subjects: 11139
Study 24582801 — intervention group
Group type: EXPERIMENTAL
Intervention: Infectious disease (HR=1.48, <1 year after diagnosis; HR=5.28, 1-5 years after diagnosis)
Number of subjects: 11139
Study 24582801 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes mellitus and hypertension
Number of subjects: 11139
Study 22414293 — intervention group
Group type: EXPERIMENTAL
Intervention: Phased multi-channel social norm marketing campaign addressing normative discrepancies (n = 25 intervention)
Number of subjects: 4000
Study 22414293 — intervention group
Group type: COMPARATOR
Intervention: Normal practice (n = 25 control)
Number of subjects: 4000
Study 22414293 — intervention group
Group type: EXPERIMENTAL
Intervention: Phased multi-channel social norm marketing campaign
Number of subjects: 4000
Study 22414293 — intervention group
Group type: COMPARATOR
Intervention: Normal practice
Number of subjects: 4000
Study 19798465 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition (EN) - elemental diet infusion during night-time and a low fat diet during daytime; 32 patients in the EN group.
Number of subjects: 56
Study 19798465 — intervention group
Group type: COMPARATOR
Intervention: Non-nutritional therapy (non-EN) - no nutritional therapy or food restriction; 24 patients in the non-EN group.
Number of subjects: 56
Study 17622759 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg sarpogrelate, orally, three times daily for 7 days
Number of subjects: 47
Study 17622759 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg sarpogrelate, orally, three times daily for 7 days
Number of subjects: 47
Study 17622759 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg sarpogrelate, orally, three times daily for 7 days
Number of subjects: 47
Study 15598456 — intervention group
Group type: EXPERIMENTAL
Intervention: ACL deficient knee during terminal swing phase
Number of subjects: 0
Study 15598456 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinematic changes during swing phase
Number of subjects: 0
Study 15598456 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnitude of the flexion moment during weight acceptance
Number of subjects: 0
Study 15598456 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptations to muscle firing patterns during walking
Number of subjects: 0
Study 15598456 — intervention group
Group type: EXPERIMENTAL
Intervention: Altered rotational position during walking
Number of subjects: 0
Study 12177804 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg (n=12)
Number of subjects: 23
Study 12177804 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole 10 mg (n=11)
Number of subjects: 23
Study 12177804 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg or 10 mg)
Number of subjects: 23
Study 10205205 — intervention group
Group type: EXPERIMENTAL
Intervention: Prucalopride 0.5 mg
Number of subjects: 50
Study 10205205 — intervention group
Group type: EXPERIMENTAL
Intervention: Prucalopride 2 mg
Number of subjects: 50
Study 10205205 — intervention group
Group type: EXPERIMENTAL
Intervention: Prucalopride 4 mg
Number of subjects: 50
Study 10205205 — intervention group
Group type: EXPERIMENTAL
Intervention: Prucalopride (0.5, 2, and 4 mg doses)
Number of subjects: 50
Study 10205205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 8548946 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin plus 17 beta‐oestradiol and medroxyprogesterone acetate (Group 2)
Number of subjects: 50
Study 8548946 — intervention group
Group type: COMPARATOR
Intervention: Goserelin alone (Group 1)
Number of subjects: 50
Study 8548946 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 50
Study 2634113 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive coupon combined with a prompt and information packet (47 subjects)
Number of subjects: 96
Study 2634113 — intervention group
Group type: COMPARATOR
Intervention: No coupon (control group, 49 subjects)
Number of subjects: 96
Study 329939 — intervention group
Group type: EXPERIMENTAL
Intervention: Layered monofilament nylon
Number of subjects: 357
Study 329939 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass polyglycolic acid
Number of subjects: 357
Study 329939 — intervention group
Group type: EXPERIMENTAL
Intervention: Steel sutures
Number of subjects: 357
Study 31963700 — intervention group
Group type: EXPERIMENTAL
Intervention: Group green exercise (running in a group of 4-5 participants)
Number of subjects: 40
Study 31963700 — intervention group
Group type: COMPARATOR
Intervention: Lone green exercise (running alone)
Number of subjects: 40
Study 30102872 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimalist shoes
Number of subjects: 50
Study 30102872 — intervention group
Group type: COMPARATOR
Intervention: Conventional shoes
Number of subjects: 50
Study 27804205 — intervention group
Group type: EXPERIMENTAL
Intervention: Two mini dental implants with Equator attachments
Number of subjects: 60
Study 27804205 — intervention group
Group type: EXPERIMENTAL
Intervention: Four mini dental implants with Equator attachments
Number of subjects: 60
Study 27804205 — intervention group
Group type: COMPARATOR
Intervention: Two conventional dental implants with ball attachments
Number of subjects: 60
Study 25581916 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 300
Study 25581916 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 23972276 — intervention group
Group type: EXPERIMENTAL
Intervention: Health system navigator intervention
Number of subjects: 0
Study 23972276 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 21353663 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention training to threat
Number of subjects: 0
Study 21353663 — intervention group
Group type: COMPARATOR
Intervention: Placebo training
Number of subjects: 0
Study 19474134 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed casein (CASH)
Number of subjects: 10
Study 19474134 — intervention group
Group type: COMPARATOR
Intervention: Intact casein (CAS)
Number of subjects: 10
Study 16952777 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music (n=89)
Number of subjects: 170
Study 16952777 — intervention group
Group type: COMPARATOR
Intervention: No music (n=81)
Number of subjects: 170
Study 14759242 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin + sulbactam (n = 37)
Number of subjects: 95
Study 14759242 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin (n = 33) +/- cephalosporin
Number of subjects: 95
Study 14759242 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 95
Study 11770191 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol + Trimegestone 0.5 mg
Number of subjects: 487
Study 11770191 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol + Trimegestone 0.25 mg
Number of subjects: 487
Study 11770191 — intervention group
Group type: COMPARATOR
Intervention: E2 + NETA
Number of subjects: 487
Study 9783756 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 7.5 mg daily
Number of subjects: 128
Study 9783756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 7888690 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet containing 5% of total calories as refined sugar (group A)
Number of subjects: 24
Study 7888690 — intervention group
Group type: COMPARATOR
Intervention: Usual 'sucrose-free' diet (group B)
Number of subjects: 24
Study 7888690 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of individual change in HbA1c with individual change in sucrose intake (group A)
Number of subjects: 24
Study 7888690 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary assessment at baseline and follow-up
Number of subjects: 24
Study 3062529 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobunolol 0.25%
Number of subjects: 85
Study 3062529 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobunolol 0.5%
Number of subjects: 85
Study 3062529 — intervention group
Group type: COMPARATOR
Intervention: Betaxolol 0.5%
Number of subjects: 85
Study 29381374 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycemia (130 mg/dl)
Number of subjects: 20
Study 29381374 — intervention group
Group type: COMPARATOR
Intervention: Normoglycemia (95 mg/dl)
Number of subjects: 20
Study 29381374 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin and leptin levels
Number of subjects: 20
Study 29381374 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin levels
Number of subjects: 20
Study 28277490 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 500 U kg‐1 per dose in 2 ml saline intravenously, given on alternate days for a total of five doses
Number of subjects: 100
Study 28277490 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo group), 2 ml given similarly for a total of five doses
Number of subjects: 100
Study 28277490 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 100
Study 28277490 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo group)
Number of subjects: 100
Study 26590242 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose motivational interviewing (4 calls)
Number of subjects: 0
Study 26590242 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose motivational interviewing (10 calls)
Number of subjects: 0
Study 24899321 — intervention group
Group type: EXPERIMENTAL
Intervention: 2ml (10 mg) hyperbaric bupivacaine 0.5% plus 25 mg preservative free ketamine
Number of subjects: 100
Study 24899321 — intervention group
Group type: COMPARATOR
Intervention: 2ml (10mg) hyperbaric bupivacaine 0.5% plus 25μg fentanyl
Number of subjects: 100
Study 20092961 — intervention group
Group type: EXPERIMENTAL
Intervention: Bcl-2 positive tumors, 74 Gy
Number of subjects: 308
Study 20092961 — intervention group
Group type: EXPERIMENTAL
Intervention: Bcl-2 negative tumors, 74 Gy
Number of subjects: 308
Study 20092961 — intervention group
Group type: EXPERIMENTAL
Intervention: Bcl-2 expression
Number of subjects: 308